CN111743872A - 一种苯磺酸左旋氨氯地平组合物 - Google Patents
一种苯磺酸左旋氨氯地平组合物 Download PDFInfo
- Publication number
- CN111743872A CN111743872A CN202010679664.0A CN202010679664A CN111743872A CN 111743872 A CN111743872 A CN 111743872A CN 202010679664 A CN202010679664 A CN 202010679664A CN 111743872 A CN111743872 A CN 111743872A
- Authority
- CN
- China
- Prior art keywords
- polyethylene glycol
- aluminum silicate
- levamlodipine besylate
- magnesium aluminum
- levamlodipine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010679664.0A CN111743872B (zh) | 2020-07-15 | 2020-07-15 | 一种苯磺酸左旋氨氯地平组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010679664.0A CN111743872B (zh) | 2020-07-15 | 2020-07-15 | 一种苯磺酸左旋氨氯地平组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111743872A true CN111743872A (zh) | 2020-10-09 |
CN111743872B CN111743872B (zh) | 2021-05-04 |
Family
ID=72710948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010679664.0A Active CN111743872B (zh) | 2020-07-15 | 2020-07-15 | 一种苯磺酸左旋氨氯地平组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111743872B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112206214A (zh) * | 2020-11-06 | 2021-01-12 | 迪沙药业集团有限公司 | 一种用于治疗高血压的药物组合物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107737128A (zh) * | 2017-10-23 | 2018-02-27 | 威海贯标信息科技有限公司 | 一种法匹拉韦片剂组合物 |
-
2020
- 2020-07-15 CN CN202010679664.0A patent/CN111743872B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107737128A (zh) * | 2017-10-23 | 2018-02-27 | 威海贯标信息科技有限公司 | 一种法匹拉韦片剂组合物 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112206214A (zh) * | 2020-11-06 | 2021-01-12 | 迪沙药业集团有限公司 | 一种用于治疗高血压的药物组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN111743872B (zh) | 2021-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6333332B1 (en) | Stabilized pharmaceutical compositions containing bupropion hydrochloride | |
FI92903B (fi) | Pitkävaikutteisen farmaseuttisen valmisteen valmistusmenetelmä | |
US20080095841A1 (en) | Pharmaceutical Composition, Method for Producing the Same, and Method for Stabilizing Dihydropyridine Compound in the Pharmaceutical Composition | |
SA110310070B1 (ar) | تركيبة صيدلانية صلبة تشتمل على أملوديبين ولوسارتان ذات ثبات محسن | |
IE851460L (en) | Galenic retard form | |
US20080268049A1 (en) | Stable Solid Dosage Forms of Amlodipine and Benazepril | |
CN111743872B (zh) | 一种苯磺酸左旋氨氯地平组合物 | |
WO2006059217A1 (en) | Stable solid dosage forms of amlodipine besylate and processes for their preparation | |
CN113041244B (zh) | 含苯磺酸左氨氯地平水合物的组合物及其制备方法 | |
EP2934488A1 (en) | A pharmaceutical composition containing candesartan cilexetil and amlodipine | |
CN106822112B (zh) | 一种替米沙坦氨氯地平双层片的制备方法 | |
EP3429561A1 (en) | Fixed dosed pharmaceutical composition comprising amiodipine, candesartan cilexetil and hydrochlorothiazide for the treatment of hypertension. | |
CN115590833B (zh) | 高溶出度稳定性的盐酸乐卡地平片组合物及其制备方法 | |
US20060270715A1 (en) | Dosage forms of amlodipine and processes for their preparation | |
MX2015006122A (es) | Composicion farmaceutica que contiene un inhibidor de la enzima de conversion de angiotensina y un bloqueador del canal de calcio. | |
CN111671730B (zh) | 一种苯磺酸左旋氨氯地平组合物及其制备方法 | |
CN112190558A (zh) | 一种左氧氟沙星组合物 | |
CN105434383B (zh) | 一种苯磺酸左旋氨氯地平片剂及其制备方法 | |
US20220257611A1 (en) | A method of manufacturing a pharmaceutical composition comprising nefopam and acetaminophen, and the pharmaceutical composition obtained thereby | |
CN111603449A (zh) | 一种苯磺酸左旋氨氯地平片剂及其制备方法 | |
CN111110639B (zh) | 一种含有苯磺酸氨氯地平的药物组合物 | |
KR101220643B1 (ko) | 사포그릴레이트 함유 경구투여 형태의 약제 | |
CN115025057B (zh) | 一种苯磺酸氨氯地平叶酸片及其制备方法 | |
CN116983272B (zh) | 一种盐酸伊伐布雷定缓释片及其制备方法 | |
JP2019059706A (ja) | アジルサルタン又はその塩及びアムロジピン又はその塩含有錠剤の品質向上方法、並びにアジルサルタン又はその塩及びアムロジピン又はその塩含有錠剤及びその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210804 Address after: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Patentee after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Patentee before: Dijia Pharmaceutical Group Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: L-amlodipine besylate composition Effective date of registration: 20211025 Granted publication date: 20210504 Pledgee: Bank of China Limited Weihai Branch Pledgor: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Registration number: Y2021980010533 |